Individual Treatment Effect and Response to Treatment: Identification and Prediction

Abstract

Background: The individualization of treatment remains a formidable challenge in modern medicine. Randomized Controlled Trials (RCTs) provide the gold standard for assessing the Average Treatment Effect (ATE) across a population. However, translating these probabilistic, population-level metrics directly to the individual patient poses inherent challenges, as traditional statistical frameworks naturally rely on unobservable counterfactuals to define individual effects. To address this, this paper proposes a complementary methodological framework that bridges the gap between population-level statistical averages and individual-level factual realities. Methods: We shift the analytical focus from potential outcomes to factual (observed) outcomes by establishing a strict conceptual "treatment context." Departing from the traditional assumption of pure random distribution (the "gas" model), we model heterogeneous trial populations as a complex mixture of deterministically related structures and randomly scattered elements (the "soup" model). Within a binary data matrix, we deploy formal logical instruments—specifically Francis Bacon's logic of elimination and the assessment of agreements and differences—to systematically reduce hyper-dimensional clinical data and isolate covariates that are potentially causally related to the individual's treatment response (sensitivity to treatment or capacity for spontaneous recovery). Results: To separate true deterministic aggregations from random coincidence, we introduce a dynamic quantitative criterion (Cr). This threshold structurally accounts for both the multiplicity of the search space and the recurrence of observations, enabling valid, mathematically rigorous inferences to be drawn from small samples and even single cases. Conclusions: This unified framework does not refute traditional statistical paradigms but serves as a vital complement in areas where the population-oriented approach experiences fundamental difficulties. By integrating formal logic with quantitative validation, this methodology provides a data-driven heuristic for individualized clinical triage, postmarketing surveillance, and the prospective prediction of treatment responses.